Rare diseases
Investigational molecules
Locations
Back to Hungary68 clinical trials in Veszprem, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Redasemtide for Adults with Acute Ischemic Stroke Not Eligible for Standard Treatments
HungaryStudy of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
HungaryStudy of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels
HungaryLong-Term Safety Study of Plozasiran for Adults with High Triglycerides
HungaryStudy on the Effects of IMVT-1402 for Adults with Difficult-to-Treat Rheumatoid Arthritis
HungaryStudy on the Effectiveness and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab for Patients with Moderate to Severe Plaque Psoriasis
HungaryStudy on Long-term Safety and Effectiveness of ESK-001 for Patients with Moderate to Severe Plaque Psoriasis
HungaryStudy on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Not Used Biologic Treatments
HungaryStudy on the Effectiveness and Safety of ESK-001 and Apremilast for Patients with Moderate to Severe Plaque Psoriasis
HungaryStudy of sonelokimab and risankizumab in adults with psoriatic arthritis who did not respond well to previous TNF inhibitor treatment
HungaryStudy on the Effectiveness of LY4100511 for Adults with Moderate-to-Severe Plaque Psoriasis
HungaryStudy of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before
HungaryThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies evaluating novel treatments for moderate to severe plaque psoriasis, including investigations of innovative therapies like JNJ-77242113 and ESK-001.
Multiple trials focusing on efficacy assessment and treatment response durability.
Extensive research into psoriatic arthritis treatments, including trials with zasocitinib, sonelokimab, and deucravacitinib for both biologic-naïve and experienced patients.
Focus on reducing symptoms and improving quality of life for patients.
Innovative research targeting systemic lupus erythematosus and other inflammatory conditions, with studies on medications like GLPG3667 and upadacitinib.
Comprehensive evaluation of disease activity and treatment responses.
Studies examining treatments for knee osteoarthritis, including comparative analysis of different chondroitin sulfate formulations and novel compounds.
Focus on both symptom management and functional outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
